Delivery Order SPE2DR25D2216-SPE2DR26F7VD2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) with a ceiling value of $6,953.93 and ultimate completion date of December 10, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $4,598.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order is scheduled for completion by December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,819.20 by the Defense Logistics Agency (DLA) on January 8, 2026, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be completed by January 9, 2026, at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Lisinopril-HCTZ 20-25 mg tablets in a quantity of 1,000 units, with a contract value of $1,035.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,297.30 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Lisinopril-Hydrochlorothiazide 20-25 mg, a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,915.30 to AmerisourceBergen Drug Corp for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) on January 14, 2026, with a completion date of January 15, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,037.66. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for ultimate completion by December 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril-HCTZ is a...
- The Defense Logistics Agency awarded a $2,856.40 delivery order to AmerSourceBergen Drug Corp for 500 tablets of Lisinopril-HCTZ 20-25 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract is unclassified and carries no set-aside designation, indicating competitive award. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7VD2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,447.24 to AmerisourceBergen Drug Corp for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the vehicle for comprehensive pharmaceutical supply to military healthcare systems worldwide. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, delivering prescription medications and medical commodities across multiple therapeutic domains to support military treatment facilities and other government healthcare programs. This delivery order for the antihypertensive medication Lisinopril-HCTZ is consistent with the company's extensive portfolio of generic and brand-name pharmaceutical deliveries under its parent company's master contract with DLA, which encompasses specialty medications, vaccines, and other essential medical supplies required by the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/13/26 |